MENU
+Compare
RXRX
Stock ticker: NASDAQ
AS OF
Dec 20, 04:59 PM (EDT)
Price
$6.04
Change
-$0.05 (-0.82%)
Capitalization
2.36B

RXRX Recursion Pharmaceuticals Forecast, Technical & Fundamental Analysis

Industry Biotechnology
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for RXRX with price predictions
Dec 20, 2024

RXRX sees MACD Histogram crosses below signal line

RXRX saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on December 18, 2024. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 37 instances where the indicator turned negative. In of the 37 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 18, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on RXRX as a result. In of 68 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

RXRX moved below its 50-day moving average on December 18, 2024 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RXRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The 10-day moving average for RXRX crossed bullishly above the 50-day moving average on December 06, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where RXRX advanced for three days, in of 206 cases, the price rose further within the following month. The odds of a continued upward trend are .

RXRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 111 cases where RXRX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.492) is normal, around the industry mean (14.529). P/E Ratio (0.000) is within average values for comparable stocks, (87.563). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.739). RXRX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (22.936) is also within normal values, averaging (255.281).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. RXRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RXRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

RXRX is expected to report earnings to rise 20.24% to -40 cents per share on March 04

Recursion Pharmaceuticals RXRX Stock Earnings Reports
Q4'24
Est.
$-0.41
Q3'24
Missed
by $0.01
Q2'24
Missed
by $0.02
Q1'24
Beat
by $0.03
Q4'23
Beat
by $0.04
The last earnings report on November 07 showed earnings per share of -34 cents, missing the estimate of -33 cents. With 19.94M shares outstanding, the current market capitalization sits at 2.36B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
41 S Rio Grande Street
Phone
+1 385 269-0203
Employees
500
Web
https://www.recursion.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JDURX14.920.22
+1.50%
PGIM Jennison Utility R
MEIIX48.760.46
+0.95%
MFS Value I
ABMIX21.960.20
+0.92%
AMG River Road Mid Cap Value I
FOBPX19.700.15
+0.77%
Tributary Balanced Instl Plus
RTRRX8.050.05
+0.63%
Royce Small-Cap Total Return R

RXRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been loosely correlated with CRSP. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-0.99%
CRSP - RXRX
62%
Loosely correlated
+0.83%
BEAM - RXRX
61%
Loosely correlated
+8.04%
PRME - RXRX
56%
Loosely correlated
+3.94%
NTLA - RXRX
54%
Loosely correlated
+0.83%
EXAI - RXRX
52%
Loosely correlated
N/A
More